Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project

Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project

Abstract Background Differentiated thyroid cancer has been treated with radioiodine for almost 80 years, although controversial questions regarding radiation-related risks and the optimisation of treatment regimens remain unresolved. Multi-centre clinical studies are required to ensure recruitment o...

Full description

Bibliographic Details
Main Authors: Jan Taprogge, Francesca Leek, Tino Schurrat, Johannes Tran-Gia, Delphine Vallot, Manuel Bardiès, Uta Eberlein, Michael Lassmann, Susanne Schlögl, Alex Vergara Gil, the MEDIRAD WP3 Investigator Team, Glenn D. Flux
Format: Article
Language:English
Published: SpringerOpen 2020-10-01
Series:EJNMMI Physics
Subjects:
Multi-centre trial
Dosimetry
Radioiodine
Differentiated thyroid cancer
Online Access:http://link.springer.com/article/10.1186/s40658-020-00332-9

Internet

http://link.springer.com/article/10.1186/s40658-020-00332-9

Similar Items